Orforglipron Drug Interactions

Brand name
  • Foundayo
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page

The Bottom Line on Orforglipron

Most often, an interaction with orforglipron means one of the two medicines simply doesn't work as well as it should, or that one of them builds up to a higher level in your body. Blood sugar shifts come up too. Orforglipron is an everyday pill taken to help manage weight, and it carries about as many documented interactions as a typical medicine, though most of those are rated major or contraindicated.

Pairs worth knowing include ketoconazole, in its pill form and its topical form, and estradiol, which can affect how well oral contraceptives are absorbed. Because the list is long and often serious, tell every prescriber you see, a dentist or an urgent care clinic included, that you take orforglipron before anything new is started.

From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy

Check Orforglipron Against Another Drug or Supplement

Type a drug, a brand name or a supplement. We check it against every documented orforglipron interaction, supplements and herbs included.

    What Could Happen When Orforglipron Interacts

    What the 135 documented orforglipron interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.

    This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site.

    Orforglipron Interactions by Severity

    Major

    How Drug Interactions Work New to drug interactions? Six short figures, about a minute, show what can happen when Orforglipron meets another medicine: a level that rises or falls, or effects that add up. See how it works 

    Look Up Another Drug

    Still Have Questions About Orforglipron?

    Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

    About This Library

    Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

    What Each Rating Means

    Severity Levels

    • Contraindicated These should generally not be used together.
    • Major Potentially serious — often needs a change or close monitoring.
    • Moderate Can be significant — usually manageable with monitoring.
    • Minor Usually limited clinical impact.
    Back to the answer

    The References Behind Orforglipron’s Interactions

    The 13 sources our orforglipron interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →

    1. Product Information: FOUNDAYO™ oral tablet, orforglipron oral tablet. Lilly USA LLC, Indianapolis, IN, 2026. DailyMed 
    2. Wharton S, Aronne LJ, Stefanski A, et al: Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment. N Engl J Med 2025; 393(18):1796-1806. PubMed 
    3. Horn DB, Ryan DH, Kis SG, et al: Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial. Lancet 2026; 406(10522):2927-2944. DOI 
    4. Joshi GP; Abdelmalak BB; Weigel WA et al: American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on Glucagon-Like Peptide-1 (GLP-1) receptor agonists. American Society of Anesthesiologists (ASA). Schaumburg, IL. 2023.
    5. Dixit AA, Bateman BT, Hawn MT, et al: Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications. JAMA 2024; 331(19):1672-1673. PubMed 
    6. Product Information: SAXENDA(R) subcutaneous injection, liraglutide subcutaneous injection. Novo Nordisk Inc (per FDA), Plainsboro, NJ, 2023. DailyMed 
    7. Product Information: WEGOVY(R) subcutaneous injection, semaglutide subcutaneous injection. Novo Nordisk Inc (per FDA), Plainsboro, NJ, 2023. DailyMed 
    8. Product Information: FOUNDAYO™ oral tablet, orforglipron oral tablet. Lilly USA LLC, Indianapolis, IN, 2026. DailyMed 
    9. National Institute for Occupational Safety and Health (NIOSH): NIOSH list of hazardous drugs in healthcare settings, 2024. Centers for Disease Control and Prevention (CDC). Atlanta, GA. 2024. DOI 
    10. None listed: Omega-3-acid melts through foam cup. ISMP Medication Safety Alert! Acute Care 2009; 14(8):2-2.

    Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.